Azathioprine Sodium for Injection
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Azathioprine Sodium for Injection is a sterile solid prepared by the freeze-drying of an aqueous solution of Azathioprine and Sodium Hydroxide.
It contains NLT 93.0% and NMT 107.0% of the labeled amount of azathioprine (C9H7N7O2S).
2 IDENTIFICATION
A. The principal spot from the Sample solution shows the same R, value as that obtained from Standard solution A in the test for Limit of Mercaptopurine.
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
3.1 PROCEDURE
Solution A: 1.6 g/L of sodium 1-heptanesulfonate in water
Mobile phase: Methanol and Solution A (30:70). Adjust with 1 N hydrochloric acid to a pH of 3.5 ± 0.1.
Standard stock solution: 0.5 mg/mL of USP Azathioprine RS prepared as follows. Transfer USP Azathioprine RS to a suitable volumetric flask. Add 25% of the flask volume of methanol and 1% of ammonium hydroxide to the flask, swirl, and sonicate for 2 min or until dissolved. Dilute with methanol to volume.
Standard solution: 0.1 mg/mL of USP Azathioprine RS in water from the Standard stock solution
Sample solution: Nominally equivalent to 0.1 mg/mL of azathioprine in water from Azathioprine Sodium for Injection
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 254 nm
Column: 3.9-mm × 30-cm; 10-µm packing L1
Flow rate: 1.8 mL/min
Injection volume: 10 µL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2
Relative standard deviation: NMT 1.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of azathioprine (C9H7N7O2S) in the portion of Azathioprine Sodium for Injection taken:
Result = (rU/rS) × (CS/CU) × 100
rU = peak response of azathioprine from the Sample solution
rS = peak response of azathioprine from the Standard solution
CS = concentration of USP Azathioprine RS in the Standard solution (mg/mL)
CU = nominal concentration of azathioprine in the Sample solution (mg/mL)
Acceptance criteria: 93.0%-107.0%
4 PERFORMANCE TESTS
UNIFORMITY OF DOSAGE UNITS (905): Meets the requirements
5 IMPURITIES
5.1 LIMIT OF MERCAPTOPURINE
Standard solution A: 10 mg/mL of USP Azathioprine RS in dimethylformamide
Standard solution B: 100 µg/mL of USP Mercaptopurine RS in dimethylformamide
Sample solution: 10 mg/mL of Azathioprine Sodium for Injection in dimethylformamide
Chromatographic system
(See Chromatography (621), Thin-Layer Chromatography.)
Mode: TLC
Adsorbent: 0.25-mm layer of microcrystalline cellulose
Application volume: 5 µL for Standard solution A and the Sample solution, and 15 µL for Standard solution B
Developing solvent system: Butyl alcohol saturated with 5 N ammonium hydroxide
Analysis
Samples: Standard solution A, Standard solution B, and Sample solution
Proceed as directed in the chapter. Apply the Samples at points 2 cm from the bottom edge of a TLC plate. Allow the spots to dry, and develop the chromatogram in a suitable chamber until the solvent front has moved 15 cm from the point of application. Remove the plate, air-dry, and locate the spots by viewing under short- and long-wavelength UV light.
Acceptance criteria: 3.0%; any spot from the Sample solution, other than the principal spot, is not more intense than the spot from Standard solution B.
6 SPECIFIC TESTS
PH (791).
Sample solution: The contents of one container dissolved in 10 mL of water
Acceptance criteria: 9.8-11.0
BACTERIAL ENDOTOXINS TEST (85): It contains NMT 1.0 USP Endotoxin Unit/mg of azathioprine.
WATER DETERMINATION (921), Method I: NMT 7.0%, when the Test Preparation is prepared as directed for a hygroscopic specimen
OTHER REQUIREMENTS: It meets the requirements in Injections and Implanted Drug Products (1).
7 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve as described in Packaging and Storage Requirements (659), Injection Packaging, Packaging for constitution, at controlled room temperature.
USP REFERENCE STANDARDS (11).
USP Azathioprine RS
USP Mercaptopurine RS

